May 6 (Reuters) - Private biotech firm Partner Therapeutics said on Wednesday the U.S. Food and Drug Administration has ...

Findings from a phase 1b/2 study showed improvement in overall survival with amezalpat plus atezolizumab/bevacizumab vs atezolizumab/bevacizumab alone. The Food and ...

President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...